Predicting Outcomes in Tricuspid Intervention: Risk Scores and Decision Tools

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>founder - Transseptal Solutions</li><li>Grant Support/Research Contract - Abbott Vascular; Medtronic; Edwards Lifesciences; Biotronik; Boston Scientific Corporation; New Valve Technologies; Terumo Medical Corporation</li><li>Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Medtronic; Edwards Lifesciences; Xeltis; Cardiovalve</li><li>Royalty/Intellectual Property Rights - Edwards Lifesciences</li><li>Equity/Stock(s)/Options - Cardiogard; Magenta; Swissvortex; Transseptal Solutions; Occlufit; 4tech; Perifect</li></ul>